Thalassaemia Month Badge
Desirox - At a Glance
Composition: Deferasirox– 250 mg (DT)
Deferasirox– 500 mg (DT)
Type: Oral Iron Chelator
Indications: Iron Overload in:
BetaThalassaemiaMajor
Sickle Cell Disease
Dosage: 20 – 30 mg/Kg/D per day
Wednesday, May 7, 2008
Thursday, May 1, 2008
Subscribe to:
Posts (Atom)